Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) EBT Margin (2023 - 2025)

Mereo BioPharma (MREO) has disclosed EBT Margin for 2 consecutive years, with 2923.2% as the latest value for Q2 2025.

  • Quarterly EBT Margin changed N/A to 2923.2% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 13086.88% through Dec 2025, changed N/A year-over-year, with the annual reading at 8375.6% for FY2025, N/A changed from the prior year.
  • EBT Margin for Q2 2025 was 2923.2% at Mereo BioPharma, down from 7159.44% in the prior quarter.
  • The five-year high for EBT Margin was 7159.44% in Q1 2025, with the low at 2923.2% in Q2 2025.